Literature DB >> 16980462

Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype.

Jochen Seggewiss1, Karsten Becker, Oliver Kotte, Martin Eisenacher, Mohammad Reza Khoschkhoi Yazdi, Andreas Fischer, Peter McNamara, Nahed Al Laham, Richard Proctor, Georg Peters, Matthias Heinemann, Christof von Eiff.   

Abstract

In this study, full-genome DNA microarrays based on the sequence of Staphylococcus aureus N315 were used to compare the transcriptome of a clinical S. aureus strain with a normal phenotype to that of its isogenic mutant with a stable small-colony-variant (SCV) phenotype (hemB::ermB). In addition to standard statistical analyses, systems biology advances were applied to identify reporter metabolites and to achieve a more detailed survey of genome-wide expression differences between the hemB mutant and its parental strain. Genes of enzymes involved in glycolytic and fermentative pathways were found to be up-regulated in the hemB mutant. Furthermore, our analyses allowed identification of additional differences between the normal-phenotype S. aureus and the SCV, most of which were related to metabolism. Profound differences were identified especially in purine biosynthesis as well as in arginine and proline metabolism. Of particular interest, a hypothetical gene of the Crp/Fnr family (SA2424) that is part of the arginine-deiminase (AD) pathway, whose homologue in Streptococcus suis is assumed to be involved in intracellular persistence, showed significantly increased transcription in the hemB mutant. The hemB mutant potentially uses the up-regulated AD pathway to produce ATP or (through ammonia production) to counteract the acidic environment that prevails intracellularly. Moreover, genes involved in capsular polysaccharide and cell wall synthesis were found to be significantly up-regulated in the hemB mutant and therefore potentially responsible for the changed cell morphology of SCVs. In conclusion, the identified differences may be responsible for the SCV phenotype and its association with chronic and persistent infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980462      PMCID: PMC1636313          DOI: 10.1128/JB.00774-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

Review 1.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

2.  Role of the arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance.

Authors:  A Casiano-Colón; R E Marquis
Journal:  Appl Environ Microbiol       Date:  1988-06       Impact factor: 4.792

3.  Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells.

Authors:  S J Peacock; T J Foster; B J Cameron; A R Berendt
Journal:  Microbiology       Date:  1999-12       Impact factor: 2.777

4.  A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly.

Authors:  C von Eiff; C Heilmann; R A Proctor; C Woltz; G Peters; F Götz
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

5.  Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype.

Authors:  Christof von Eiff; Peter McNamara; Karsten Becker; Donna Bates; Xiang-He Lei; Michael Ziman; Barry R Bochner; Georg Peters; Richard A Proctor
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

Review 6.  Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus.

Authors:  Ambrose L Cheung; Arnold S Bayer; Gongyi Zhang; Hattie Gresham; Yan-Qiong Xiong
Journal:  FEMS Immunol Med Microbiol       Date:  2004-01-15

7.  A transcriptional activator, homologous to the Bacillus subtilis PurR repressor, is required for expression of purine biosynthetic genes in Lactococcus lactis.

Authors:  M Kilstrup; J Martinussen
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

8.  Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus.

Authors:  Franziska Schaaff; Gabriele Bierbaum; Nicole Baumert; Peter Bartmann; Hans-Georg Sahl
Journal:  Int J Med Microbiol       Date:  2003-12       Impact factor: 3.473

9.  sn-Glycerol-3-phosphate dehydrogenase and its interaction with nitrate reductase in wild-type and hem mutant strains of Staphylococcus aureus.

Authors:  J Lascelles
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

Review 10.  The FNR family of transcriptional regulators.

Authors:  S Spiro
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

View more
  43 in total

1.  Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.

Authors:  Lorena P N Tuchscherr; Fernanda R Buzzola; Lucía P Alvarez; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

2.  Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype.

Authors:  Marina Wu; Christof von Eiff; Nahed Al Laham; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 3.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.

Authors:  Brea D Duval; Anselmo Mathew; Sarah W Satola; William M Shafer
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

5.  [Persistent and recurrent skin and soft tissue infections by Staphylococcus aureus. Impact of the small colony-variant (SCV) phenotype and of Panton-Valentine leukocidin (PVL)-positive S. aureus isolates].

Authors:  K Becker; A Kriegeskorte; C Sunderkötter; B Löffler; C von Eiff
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

Review 6.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus.

Authors:  Christian Kohler; Christof von Eiff; Manuel Liebeke; Peter J McNamara; Michael Lalk; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

8.  Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.

Authors:  Wei Gao; Kyra Chua; John K Davies; Hayley J Newton; Torsten Seemann; Paul F Harrison; Natasha E Holmes; Hyun-Woo Rhee; Jong-In Hong; Elizabeth L Hartland; Timothy P Stinear; Benjamin P Howden
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

9.  Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes.

Authors:  Aleksej Zelezniak; Tune H Pers; Simão Soares; Mary Elizabeth Patti; Kiran Raosaheb Patil
Journal:  PLoS Comput Biol       Date:  2010-04-01       Impact factor: 4.475

10.  Nitric oxide stress induces different responses but mediates comparable protein thiol protection in Bacillus subtilis and Staphylococcus aureus.

Authors:  Falko Hochgräfe; Carmen Wolf; Stephan Fuchs; Manuel Liebeke; Michael Lalk; Susanne Engelmann; Michael Hecker
Journal:  J Bacteriol       Date:  2008-05-16       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.